Circadian rhythm of exhaled biomarkers in health and asthma

Circadian rhythms regulate and reflect many biological processes. Investigating circadian variability in biomarkers is important since the diurnal variability of any potential biomarker must be quantified and controlled in research and clinical practice. Time of day is particularly important in inflammatory diseases such as asthma, which are linked to exaggerated circadian rhythms. Airway narrowing in asthma is greatest at around 04:00 h and coincides with an increase in symptoms; asthma deaths are also more likely to occur at this time [1, 2]. Likewise eosinophilic airway inflammation peaks in the morning, with clinical implications for biomarker-guided steroid therapy [3]. Exhaled volatile chemicals and fractional exhaled nitric oxide oscillate over 24 h, highlighting the importance of time of day in diagnostic sampling and suggesting potential applications for chronotyping. http://bit.ly/2YZGXbH

[1]  A. Loudon,et al.  Time of Day Affects Eosinophil Biomarkers in Asthma: Implications for Diagnosis and Treatment , 2018, American journal of respiratory and critical care medicine.

[2]  Hans Weda,et al.  BreathDx – molecular analysis of exhaled breath as a diagnostic test for ventilator–associated pneumonia: protocol for a European multicentre observational study , 2017, BMC Pulmonary Medicine.

[3]  Agnieszka Smolinska,et al.  Profile of volatile organic compounds in exhaled breath changes as a result of gluten-free diet , 2013, Journal of breath research.

[4]  Julian King,et al.  Measurement of endogenous acetone and isoprene in exhaled breath during sleep , 2012, Physiological measurement.

[5]  Margaret W Leigh,et al.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. , 2011, American journal of respiratory and critical care medicine.

[6]  Ashley Woodcock,et al.  Non-invasive phenotyping using exhaled volatile organic compounds in asthma , 2011, Thorax.

[7]  António S. Barros,et al.  Profiling allergic asthma volatile metabolic patterns using a headspace-solid phase microextraction/gas chromatography based methodology. , 2011, Journal of chromatography. A.

[8]  E. Wouters,et al.  Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  P. Kakkar,et al.  Plant derived antioxidants - Geraniol and camphene protect rat alveolar macrophages against t-BHP induced oxidative stress. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  Peter J Sterk,et al.  An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.

[11]  K. Torén,et al.  Determination of ethane, pentane and isoprene in exhaled air – effects of breath‐holding, flow rate and purified air , 2007, Acta physiologica.

[12]  M. Holtzman,et al.  Developing the epithelial, viral, and allergic paradigm for asthma: Giles F. Filley lecture. , 2003, Chest.

[13]  J. B. Macdonald.  Nocturnal asthma. , 1992, BMJ.

[14]  A. Cailleux,et al.  Isoprene and sleep. , 1989, Life sciences.

[15]  T J Clark,et al.  Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. , 1980, Thorax.